Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $372.18 -3.18%
EPS Growth %: -1.3%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: -1.3%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference
- BrightSpring Health Services, Inc. (BTSG) Tops Q3 EPS by 34c ; Offers Guidance
- AbbVie (ABBV) Tops Q3 EPS by 8c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
